Leveraging mHealth and Patient Supporters for African Americans' and Latinxs' Engagement in HIV Care (LEAN): Protocol for a Randomized, Controlled, Effectiveness-Implementation Trial
- PMID: 36787165
- PMCID: PMC9975915
- DOI: 10.2196/42691
Leveraging mHealth and Patient Supporters for African Americans' and Latinxs' Engagement in HIV Care (LEAN): Protocol for a Randomized, Controlled, Effectiveness-Implementation Trial
Abstract
Background: Despite substantial investments in ending the HIV epidemic, disparities in HIV care persist, and there is an urgent need to evaluate novel and scalable approaches to improving HIV care engagement and viral suppression in real-world settings.
Objective: This paper aims to describe a study protocol for a pragmatic type II hybrid effectiveness-implementation randomized controlled trial comparing existing standard of care clinic HIV linkage, adherence, and retention (LAR) protocols to a mobile health (mHealth)-enhanced linkage, adherence, and retention (mLAR) intervention.
Methods: The study will enroll 450 participants from clinics in Baltimore City. Eligibility criteria include being ≥18 years of age, having a new HIV diagnosis or being HIV-positive and out of care, or being HIV-positive and deemed by clinic staff as someone who could benefit from linkage and retention services. Participants randomized to the intervention receive mHealth-supported patient navigation for 12 months. Participants in the control group receive the referring clinic's standard of care patient support. The primary outcome is HIV virologic suppression at 12 months. A subset of participants will be interviewed at 12 months to learn about their HIV care experiences and, for those in the intervention arm, their experiences with the mLAR intervention. This protocol was developed in collaboration with the Baltimore City Health Department (BCHD) and the Maryland Department of Health (MDH) and with input from a community advisory board.
Results: Enrollment began on February 25, 2020. As of August 11, 2022, 411 of the 450 target participants had been enrolled.
Conclusions: Pragmatic implementation science trials designed with input from key stakeholders, including health departments and community members, can help evaluate the evidence for mHealth interventions to reduce HIV health disparities.
Trial registration: ClinicalTrials.gov NCT03934437; https://clinicaltrials.gov/ct2/show/NCT03934437.
International registered report identifier (irrid): DERR1-10.2196/42691.
Keywords: HIV continuum of care; HIV linkage to care; HIV virologic suppression; adherence; implementation; mHealth.
©Joyce Jones, Jane McKenzie-White, Ronald Saxton, Suzanne M Grieb, Bareng Nonyane, Cadeesha Graham, Anthony Cano, Sheridan Johnson, Lanisha Childs, Adena Greenbaum, Colin Flynn, Marcia Pearlowitz, Shivaun Celano, Larry W Chang, Kathleen R Page. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 14.02.2023.
Conflict of interest statement
Conflicts of Interest: Under a licensing agreement between emocha Mobile Health and the Johns Hopkins University, LWC, KRP, and JM-W are entitled to royalties on an invention described in this article. LWC and JM-W are also consultants to emocha Mobile Health. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies.
Figures




References
-
- Monitoring selected national HIV prevention and care objectives by using HIV surveillance data: United States and 6 dependent areas. CDC. 2019. [2022-12-23]. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveil... .
-
- Rao S, Seth P, Walker T, Wang G, Mulatu MS, Gilford J, German EJ. HIV Testing and Outcomes Among Hispanics/Latinos - United States, Puerto Rico, and U.S. Virgin Islands, 2014. MMWR Morb Mortal Wkly Rep. 2016 Oct 14;65(40):1099–1103. doi: 10.15585/mmwr.mm6540a2. doi: 10.15585/mmwr.mm6540a2. - DOI - DOI - PubMed
-
- Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493–505. doi: 10.1056/NEJMoa1105243. https://europepmc.org/abstract/MED/21767103 - DOI - PMC - PubMed
Associated data
LinkOut - more resources
Full Text Sources